Yingbiao Ji

Yingbiao Ji is a Senior Scientist at Frontage Laboratories, Inc, specializing in the development of bioanalytical methods for assessing immunogenicity related to biotherapeutics and Adeno-Associated Viruses, since September 2021. Prior experience includes roles as a Research Associate at Fox Chase Cancer Center, where research focused on HBV transcription mechanisms, and as a Postdoctoral Researcher at the University of Pennsylvania, investigating the activation of EGFR by trefoil factors. Additional experience encompasses two significant positions at Fox Chase Cancer Center, exploring PARP1 inhibitors and splicing mechanisms, along with a postdoctoral fellowship at Auburn University, centered on defensins and intestinal homeostasis. Yingbiao Ji holds a Ph.D. in Molecular Genetics from the University of New Brunswick, earned between 1999 and 2005.